InvestorsHub Logo
Followers 12
Posts 1060
Boards Moderated 0
Alias Born 06/29/2017

Re: None

Monday, 07/10/2017 12:08:48 PM

Monday, July 10, 2017 12:08:48 PM

Post# of 89
Company highlights to date

3D Signatures is developing a technology to diagnose 14 different diseases with unprecedented accuracy, from prostate cancer to Alzheimer's, all with a simple blood test, cheek swab, or tissue sample. This work is supported by over 130 peer reviewed papers and 2000 patients. Our short video HERE will explain better than I can.

Recently, our software platform has attracted partnership discussions from major biopharma companies. You can catch quite a few additional company highlights in the investor section of our website

We anticipate our first clinical product for commercial use by the end of 2017